DOI QR코드

DOI QR Code

The Ross Procedure in Pediatric Patients: A 20-Year Experience of Ross Procedure in a Single Institution

  • Yoon, Dong Woog (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Ji-Hyuk (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Jun, Tae-Gook (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Pyo Won (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2016.09.19
  • Accepted : 2016.11.03
  • Published : 2017.08.05

Abstract

Background: The Ross/Ross-Konno procedure is considered a good option for irreparable aortic valve disease in pediatric patients because of its hemodynamic performance and potential for growth of the pulmonary autograft. This study is a review of the long-term results of our 20-year experience with the Ross and Ross-Konno operations in a single institution. Methods: Between June 1995 and January 2016, 16 consecutive patients (mean age, $6.0{\pm}5.9years$; range, 16 days to 17.4 years) underwent either a Ross operation (n=9) or a Ross-Konno operation (n=7). The study included 12 males and 4 females, with a median follow-up period of 47 months (range, 6 to 256 months). Results: There were no cases of in-hospital or late mortality. Six reoperations were performed in 5 patients. Four patients underwent right ventricular-pulmonary artery (RV-PA) conduit replacement. Two patients underwent concomitant replacement of the pulmonary autograft and RV-PA conduit 10 years and 8 years after the Ross operation, respectively. The rate of freedom from adverse outcomes of the pulmonary autograft was 88% and 70% at 5 and 10 years, respectively. The rate of freedom from valve-related reoperations was 79% and 63% at 5 and 10 years, respectively. Conclusion: Pulmonary autografts demonstrated good durability with low mortality. The Ross/Ross-Konno procedure is a good option that can be performed safely in pediatric patients with aortic valve disease, even in a small-volume center.

Keywords

References

  1. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967;2:956-8.
  2. Al-Halees Z, Pieters F, Qadoura F, Shahid M, Al-Amri M, Al-Fadley F. The Ross procedure is the procedure of choice for congenital aortic valve disease. J Thorac Cardiovasc Surg 2002;123:437-41. https://doi.org/10.1067/mtc.2002.119705
  3. Takkenberg JJ, Klieverik LM, Schoof PH, et al. The Ross procedure: a systematic review and meta-analysis. Circulation 2009;119:222-8. https://doi.org/10.1161/CIRCULATIONAHA.107.726349
  4. David TE, Omran A, Ivanov J, et al. Dilation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg 2000;119:210-20. https://doi.org/10.1016/S0022-5223(00)70175-9
  5. Jonas RA. The Ross procedure is not the procedure of choice for the teenager requiring aortic valve replacement. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2005;8:176-80. https://doi.org/10.1053/j.pcsu.2005.01.019
  6. Elkins RC, Thompson DM, Lane MM, Elkins CC, Peyton MD. Ross operation: 16-year experience. J Thorac Cardiovasc Surg 2008;136:623-30. https://doi.org/10.1016/j.jtcvs.2008.02.080
  7. Tan Tanny SP, Yong MS, d'Udekem Y, et al. Ross procedure in children: 17-year experience at a single institution. J Am Heart Assoc 2013;2:e000153.
  8. Brancaccio G, Polito A, Hoxha S, et al. The Ross procedure in patients aged less than 18 years: the midterm results. J Thorac Cardiovasc Surg 2014;147:383-8. https://doi.org/10.1016/j.jtcvs.2013.02.037
  9. Bansal N, Kumar SR, Baker CJ, Lemus R, Wells WJ, Starnes VA. Age-related outcomes of the Ross procedure over 20 years. Ann Thorac Surg 2015;99:2077-83. https://doi.org/10.1016/j.athoracsur.2015.02.066
  10. Nelson JS, Pasquali SK, Pratt CN, et al. Long-term survival and reintervention after the Ross procedure across the pediatric age spectrum. Ann Thorac Surg 2015;99:2086-94. https://doi.org/10.1016/j.athoracsur.2015.02.068
  11. Schneider AW, Bokenkamp R, Bruggemans EF, Hazekamp MG. Twenty-year experience with the Ross-Konno procedure. Eur J Cardiothorac Surg 2016;49:1564-70. https://doi.org/10.1093/ejcts/ezv434
  12. Mookhoek A, Charitos EI, Hazekamp MG, et al. Ross procedure in neonates and infants: a European multicenter experience. Ann Thorac Surg 2015;100:2278-84. https://doi.org/10.1016/j.athoracsur.2015.08.008
  13. Lo Rito M, Davies B, Brawn WJ, et al. Comparison of the Ross/Ross-Konno aortic root in children before and after the age of 18 months. Eur J Cardiothorac Surg 2014;46:450-7. https://doi.org/10.1093/ejcts/ezt631
  14. Shinkawa T, Bove EL, Hirsch JC, Devaney EJ, Ohye RG. Intermediate-term results of the Ross procedure in neonates and infants. Ann Thorac Surg 2010;89:1827-32. https://doi.org/10.1016/j.athoracsur.2010.02.107
  15. Laudito A, Brook MM, Suleman S, et al. The Ross procedure in children and young adults: a word of caution. J Thorac Cardiovasc Surg 2001;122:147-53. https://doi.org/10.1067/mtc.2001.113752
  16. David TE, David C, Woo A, Manlhiot C. The Ross procedure: outcomes at 20 years. J Thorac Cardiovasc Surg 2014;147:85-93. https://doi.org/10.1016/j.jtcvs.2013.08.007
  17. Mookhoek A, de Kerchove L, El Khoury G, et al. European multicenter experience with valve-sparing reoperations after the Ross procedure. J Thorac Cardiovasc Surg 2015;150:1132-7. https://doi.org/10.1016/j.jtcvs.2015.08.043
  18. Yang JH, Jun TG, Sung K, Kim WS, Lee YT, Park PW. Midterm results of size-reduced cryopreserved homografts for right ventricular outflow tract reconstruction. Ann Thorac Surg 2010;89:1821-6. https://doi.org/10.1016/j.athoracsur.2010.03.009
  19. Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg 1998;115:111-7. https://doi.org/10.1016/S0022-5223(98)70449-0